NTRN (Neutron) 24-hour amplitude reaches 78.6%: Binance delisting announcement triggers trading surge and price pump followed by pullback
Bitget Pulse2026/04/01 02:22Volatility Overview
In the past 24 hours, the price of NTRN rose from a low of $0.0014 to a high of $0.0025, currently trading at $0.0015, with a price amplitude of 78.6%. Trading volume has significantly expanded. According to CoinGecko, 24-hour trading volume reached $1,559,400, up 132.20% from the previous period; CoinMarketCap shows the volume around $3,026,100.
Brief Analysis of the Cause of Abnormal Movements
- Binance Delisting Announcement: Binance announced that it will remove the NTRN spot trading pair on April 1, 2026. This news directly triggered a surge in trading activity, causing a brief price pump (Bitget data shows a 24-hour range from $0.00194 to a high of $0.002829, amplitude 47.4%), followed by a pullback.
- Futures Market Linkage: Binance futures NTRN rose as much as 25.4%, amplifying spot market volatility.
Market Views and Outlook
The prevailing market sentiment remains cautious, with community discussions focusing on delisting risks and "last pump" opportunities. Finora AI analysis stated that the +10.8% surge accompanied by a 5.2x increase in trading volume could be whale-driven, but warned of a potential retracement toward the support below $0.0037, and advised waiting for confirmation to avoid FOMO; CoinGecko shows the price has cumulatively fallen 34.75%, and analysts caution that liquidity may further tighten after delisting.
Note: This analysis was automatically generated by AI based on public data and on-chain monitoring and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs
AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.
A Major Reversal Amid the U.S. Bond Selloff! Bond Market Veteran Bianco Turns Bullish for the First Time in Six Years, Calling 5% Yield a "Value Buy Opportunity"
Currently, as benchmark U.S. Treasury yields surge to their highest levels in nearly two decades, bond market veteran Jim Bianco has loosened his bearish stance for the first time and is gradually building long positions as a "value buyer."
Crypto prices
More
